Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Historical Holders from Q4 2019 to Q4 2024

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
APRE on Nasdaq
Shares outstanding
5,434,244
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.9% $269,650 539,300 Orin Hirschman 31 Dec 2024
Sio Capital Management, LLC 5.1% $138,302 276,603 Sio Capital Management, LLC 31 Dec 2024

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2024 Q4 0 $0 -$2,000 0
2024 Q3 899 $2,000 $0 222.47% 1
2024 Q2 899 $3,000 -$669 333.7% 1
2024 Q1 999 $6,669 +$6,000 668.21% 2
2023 Q4 100 $470 $0 470% 1
2023 Q3 100 $417 $0 417% 1
2023 Q2 100 $315 -$13 315% 1
2023 Q1 103 $457 -$520,106 438.67% 2
2022 Q4 1,587,074 $520,280 -$29,540 33.1% 23
2022 Q3 1,676,180 $1,090,201 -$364,644 65.04% 20
2022 Q2 1,467,372 $1,097,000 -$868,871 74.62% 25
2022 Q1 2,418,438 $4,501,000 -$2,768,399 186.18% 38
2021 Q4 3,609,994 $10,360,000 -$8,429,255 286.96% 34
2021 Q3 4,969,623 $25,395,281 -$7,621,116 511.01% 36
2021 Q2 6,538,895 $31,908,000 -$11,846,977 487.98% 48
2021 Q1 8,902,107 $45,255,770 -$6,915,082 509.89% 65
2020 Q4 9,448,466 $46,484,000 -$98,051,463 491.87% 60
2020 Q3 16,566,027 $398,570,000 +$3,158,144 2,405.95% 62
2020 Q2 16,311,535 $632,557,282 +$111,950,147 3,878% 62
2020 Q1 13,443,861 $466,494,276 +$17,900,174 3,475.99% 49
2019 Q4 12,931,705 $591,290,000 +$460,153,112 4,588.98% 39